Article

timesfreepress.com on 2024-04-01 06:00

Time capsule: Sanofi-Aventis acquired Chattem in 2009 for $1.9 billion

One of Chattanooga's legacy businesses changed hands in 2009, when Chattem was purchased for $1.9 billion by France-based Sanofi-Aventis.

Related news

LGlobal Lung Cancer Treatment Drugs Market 2021 Future Set to Massive Growth with High CAGR value | Market Players: Roche, AstraZeneca, Eli Lilly and Company, Sanofi-Aventis, Pfizer, GlaxoSmithKline…liverpoolstudentmedia.com
Africa , Middle East , Mexico , Brazil , Latin America
UInsulin API Market Size Current and Future | Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, Ganlee unlvrebelyell.com
Africa , Middle East , Pacific Ocean , Asia
KMultiple Sclerosis Drugs Market Analysis and Research | Bayer Healthcare, Pfizer, TG Therapeutics, arGEN-x, Sanofi-Aventis ksusentinel.com
KDocetaxel Market Reviews and Outlook 2021-2026 | : Sanofi-Aventis, Pfizer, Teva, Taj Pharmaceuticals ksusentinel.com
Africa , Middle East , Latin America , Pacific Ocean , Asia
KAntibiotics Drugs Market Size 2021-2028 Glaxo Smithkline, Johnson & Johnson, Sanofi-Aventis ksusentinel.com
UGlobal Biologics and Biosimilars Market 2021 Status and Growth Outlook| Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson unlvrebelyell.com
LGlobal RNA-based Biopharmaceuticals Market 2021 Regional Analysis and Major Manufacturers as Pfizer, Roche, Sanofi-Aventis, Abbott Laboratories liverpoolstudentmedia.com
LGlobal Bisphosphonate Drug Market 2021 Future Set to Massive Growth with High CAGR value | Market Players: Merck, Sanofi-Aventis, Apotex Corp, Teva, Novartis Pharmaceuticals, Mylan, Genentech, Coba…liverpoolstudentmedia.com
BKadmon Stock Soars as Sanofi Buys U.S. Biotech for $1.9 Billion 1 min read barrons.com
Lyon , France
BTranslate Bio Stock Up 50% as Sanofi Commits $1.9 Billion to Its Covid-19 Vaccine barrons.com
France
Sanofi-Aventis U.S., LLC v. Dr. Reddy’s Labs., Inc.jdsupra.com
California , United States , Switzerland
Sanofi-Aventis Deutschlan GMBH v. Mylan Pharmaceuticals Inc.jdsupra.com
Sanofi-Aventis U.S. LLC v. Sandoz, Inc. Jevtana® (Cabazitaxel)jdsupra.com
KRNA-based Biopharmaceuticals Market 2021: Potential growth, attractive valuation make it is a long-term investment | Know the COVID19 Impact | Top Players: Pfizer, Roche, Sanofi-Aventis, Abbott Laboratories, Arrowhead Pharmaceuticals, etc.ksusentinel.com
Sanofi-Aventis U.S. LLC v. Apotex Corp. Jevtana® (Cabazitaxel)jdsupra.com
Sanofi, Sanofi-Aventis U.S., LLC V. Watson Labs. Inc., Sandoz, Inc.jdsupra.com
LHigh Performance Active Pharmaceutical Ingredients (Hpapi) Market Recovery and Impact Analysis Report – Novartis, Pfizer, Sanofi Aventis liverpoolstudentmedia.com
Sanofi-Aventis U.S., LLC v. Fresenius Kabi USA, LLC (Fed. Cir. 2019)jdsupra.com
California , United States , Switzerland
Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2023)jdsupra.com
Venice
Cabilly II IPR Update: Sanofi-Aventis U.S. LLC v. Genentech, Inc.jdsupra.com